Japanese medical device manufacturer Terumo has announced an agreement to acquire UK-based organ medical technology company OrganOx in a transaction valued at approximately $1.5 billion. The deal marks Terumo’s strategic move into the organ transplant sector, expanding its portfolio in the healthcare space.
OrganOx specializes in devices used to preserve and improve the viability of organs for transplantation, with its flagship product being an innovative organ perfusion system. The acquisition will enable Terumo to strengthen its presence in the growing organ transplant market and develop advanced solutions for organ preservation and transplantation processes.
The deal is expected to be completed after regulatory approvals and customary closing conditions. Industry analysts view this move as part of Terumo’s broader strategy to diversify its offerings and invest in high-growth medical technologies. No further details about the integration process or future plans were disclosed.